Home
>
National Drug Code (NDC)
>
Ramipril
Ramipril - 31722-271-01 - (Ramipril)
Drug Information of Ramipril
| Product NDC: | 31722-271 |
| Proprietary Name: | Ramipril |
| Non Proprietary Name: | Ramipril |
| Active Ingredient(s): | 1.25 mg/1 & nbsp; Ramipril |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ramipril
| Product NDC: | 31722-271 |
| Labeler Name: | Camber Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078745 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110101 |
Package Information of Ramipril
| Package NDC: | 31722-271-01 |
| Package Description: | 24 BOTTLE in 1 CASE (31722-271-01) > 100 CAPSULE in 1 BOTTLE |
NDC Information of Ramipril
| NDC Code | 31722-271-01 |
| Proprietary Name | Ramipril |
| Package Description | 24 BOTTLE in 1 CASE (31722-271-01) > 100 CAPSULE in 1 BOTTLE |
| Product NDC | 31722-271 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ramipril |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20110101 |
| Marketing Category Name | ANDA |
| Labeler Name | Camber Pharmaceuticals |
| Substance Name | RAMIPRIL |
| Strength Number | 1.25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
